Prostatic Size Reduction Following of Leuprorelin Acetate
Recruiting
Observational Study
Prostate Cancer Adenocarcinoma
Prostate Adenocarcinoma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 95
- Sex
- Male
- Study type
- Observational
- Participants needed
- 40 (estimated)
- Sponsor
- Consorci Sanitari de Terrassa · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
To determine the possible reduction in prostate size following the administration of Leuprelin prior to the application of radiotherapy.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Man with Prostate positive biopsy. Able to Ssgned informed consent form. Need of hormonal treatment before start of radiotherapy
Exclusion Criteria:
Patients With prostate size of less than 20 cc at diagnosis. Patients With Positive lymph nodes or metastatic prostate cancer di…
Contacts